Mark S. Levine, Chief Legal Officer at Immunovant, Inc. (IMVT), sold 6,008 shares at $37.91 ($228K) on 2024-01-26, disclosed to the SEC on 2024-01-29.
Open-market sale of $228k IMVT by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.91 | 2,981 | $113K | 49.6% |
| 2 | $37.91 | 2,981 | $113K | 49.6% |
| 3 | $38.45 | 46 | $2K | 0.8% |
| Total | $37.91 avg | 6,008 | $228K | 100% |
| Filing → |
| IMVT | SELL | 2024-10-18 | $165K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $206K | — | Filing → |
| IMVT | SELL | 2024-07-26 | $223K | — | Filing → |